SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
After testing ResMed's new sleep apnoea therapy platform, patients rate the S9 Series as significantly better than their current device in comfort of breathing, dryness of nose and mouth, rainout, and ...
ResMed (NYSE:RMD), a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, today introduced its new cutting-edge sleep apnoea therapy platform called the S9 ...
The S9 Elite™ is a whisper quiet, elegant and comfortable therapy system for the treatment of Obstructive Sleep Apnoea (OSA). The S9 Elite provides Continuous Positive Airway Pressure (CPAP) with Easy ...
Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion ...
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...
As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results